首页> 外文期刊>Theriogenology >Expression and localization of locally produced growth factors regulating lymphangiogenesis during different stages of the estrous cycle in corpus luteum of buffalo (Bubalus bubalis).
【24h】

Expression and localization of locally produced growth factors regulating lymphangiogenesis during different stages of the estrous cycle in corpus luteum of buffalo (Bubalus bubalis).

机译:水牛黄体(Bubalus bubalis)动情周期不同阶段中调节淋巴管生成的局部生长生长因子的表达和定位。

获取原文
获取原文并翻译 | 示例
           

摘要

Recent experiments using expression, immunolocalization, and cell culture approaches have provided leading insights into regulation of luteal angiogenesis by different growth factor systems and its role in the function of corpus luteum (CL) in buffalo. On the contrary, lymphangiogenesis and its regulation in the CL are still poorly understood. The aim of this study was to evaluate the expression and localization of lymphangiogenic factors (vascular endothelial growth factor [VEGF]-C and VEGFD), their receptor (VEGFR3), and lymphatic endothelial marker (LYVE1) in bubaline CL during different stages of the estrous cycle and to investigate functional role of VEGFC and VEGFD in luteal lymphangeogenesis. The mRNA and protein expression of VEGFC, VEGFD, and VEGFR3 was significantly greater in mid and late luteal phases, which correlated well with the expression of LYVE1. The lymphangiogenic factors were localized in luteal cells, exclusively in the cytoplasm. Immunoreactivity of VEGFC was greater during midluteal phase and that of VEGFD was greater during the mid and late luteal phases. Luteal cells were cultured in vitro and treated for different time duration (24, 48, and 72 hours) with VEGFC and VEGFD each at 50, 100, and 150 ng/mL concentration and VEGFC with VEGFD at 100 ng/mL concentration. The temporal increase in LYVE1 mRNA expression was significant (P<0.05) in VEGFC and VEGFC with VEGFD treatment and no significant change was seen in VEGFD treatment. Thus, it seems likely that VEGFD itself has little role in lymphangiogenesis but along with VEGFC it might have a synergistic effect on VEGFR3 receptors for inducing lymphangiogenesis. In summary, the present study provided evidence that VEGFC and VEGFD, and their receptor VEGFR3, are expressed in bubaline CL and are localized exclusively in the cell cytoplasm, suggesting that these factors have a functional role in lymphangiogenesis of CL in buffalo.
机译:最近使用表达,免疫定位和细胞培养方法进行的实验已为不同生长因子系统对黄体血管生成的调控及其在水牛黄体(CL)功能中的作用提供了领先的见识。相反,对淋巴管生成及其在CL中的调控仍知之甚少。这项研究的目的是评估在淋巴结转移的不同阶段,淋巴管生成因子(血管内皮生长因子[VEGF] -C和VEGFD),它们的受体(VEGFR3)和淋巴管内皮标记(LYVE1)的表达和定位。发情周期并研究VEGFC和VEGFD在黄体淋巴管生成中的功能。在黄体中期和晚期,VEGFC,VEGFD和VEGFR3的mRNA和蛋白表达显着较高,这与LYVE1的表达密切相关。淋巴管生成因子位于黄体细胞中,仅位于细胞质中。在黄体中期,VEGFC的免疫反应性更高,在黄体中期和后期,VEGFD的免疫反应性更高。黄体细胞在体外培养,并分别以50、100和150 ng / mL的浓度分别用VEGFC和VEGFD和100ng / mL浓度的VEGFC处理不同的持续时间(24、48和72小时)。 VEGFD处理后,VEGFC和VEGFC中LYVE1 mRNA的表达随时间的增加显着(P <0.05),而在VEGFD处理中未见明显变化。因此,似乎VEGFD本身在淋巴管生成中几乎没有作用,但是与VEGFC一起可能对VEGFR3受体具有协同作用以诱导淋巴管生成。总而言之,本研究提供了证据,VEGFC和VEGFD及其受体VEGFR3在水泡CL中表达并且仅位于细胞质中,提示这些因素在水牛CL的淋巴管生成中具有功能性作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号